Literature DB >> 15509455

Biologic poisons for pain.

Lori Reisner1.   

Abstract

Pain therapies from natural sources date back thousands of years to the use of plant and animal extracts for a variety of painful conditions and injuries. We certainly are all familiar with modern uses of plant-derived analgesic compounds such as opium derivatives from papaverum somniferum and salicylates from willow bark (Salix species). Local anesthetics were isolated from coca leaves in the late 1800s. Sarapin, derived from carnivorous pitcher plants, has been injected for regional analgesia in human and veterinary medicine, but efficacy is controversial. Biologic organisms can play important roles in developing an understanding of pain mechanisms, either from isolation of compounds that are analgesic or of compounds that produce pain, hyperalgesia, and allodynia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15509455     DOI: 10.1007/s11916-004-0063-3

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  51 in total

1.  The synthesis of SO-3, a conopeptide with high analgesic activity derived from Conus striatus.

Authors:  Qiuyun Dai; Fengyun Liu; Yanrong Zhou; Baisong Lu; Fang Yu; Peitang Huang
Journal:  J Nat Prod       Date:  2003-09       Impact factor: 4.050

Review 2.  Drugs from the sea: conotoxins as drug leads for neuropathic pain and other neurological conditions.

Authors:  D Alonso; Z Khalil; N Satkunanthan; B G Livett
Journal:  Mini Rev Med Chem       Date:  2003-11       Impact factor: 3.862

Review 3.  The role of TRP channels in sensory neurons.

Authors:  Martin Koltzenburg
Journal:  Novartis Found Symp       Date:  2004

4.  Signal transduction events in lung injury induced by 2-chloroethyl ethyl sulfide, a mustard analog.

Authors:  Diptendu Chatterjee; Shyamali Mukherjee; Milton G Smith; Salil K Das
Journal:  J Biochem Mol Toxicol       Date:  2003       Impact factor: 3.642

5.  Mechanism of action of botulinum toxin type A in migraine prevention: a pilot study.

Authors:  Johan A Smuts; Donovan Schultz; Adri Barnard
Journal:  Headache       Date:  2004-09       Impact factor: 5.887

Review 6.  Anesthetic considerations of the herbal, kava.

Authors:  Kevin M Raduege; James F Kleshinski; J Victor Ryckman; John E Tetzlaff
Journal:  J Clin Anesth       Date:  2004-06       Impact factor: 9.452

7.  Inhibitory effect of anandamide on resiniferatoxin-induced sensory neuropeptide release in vivo and neuropathic hyperalgesia in the rat.

Authors:  Zsuzsanna Helyes; József Németh; Márta Thán; Kata Bölcskei; Erika Pintér; János Szolcsányi
Journal:  Life Sci       Date:  2003-09-19       Impact factor: 5.037

Review 8.  Small conductance Ca2+-activated K+ channels as targets of CNS drug development.

Authors:  Thomas Blank; Ingrid Nijholt; Min-Jeong Kye; Joachim Spiess
Journal:  Curr Drug Targets CNS Neurol Disord       Date:  2004-06

Review 9.  Intrathecal ziconotide for refractory pain.

Authors:  Sheila A Doggrell
Journal:  Expert Opin Investig Drugs       Date:  2004-07       Impact factor: 6.206

10.  Intrathecally administered cholera toxin blocks allodynia and hyperalgesia in persistent pain models.

Authors:  R M Caudle; A J Mannes; R Benoliel; E Eliav; M J Iadarola
Journal:  J Pain       Date:  2001-04       Impact factor: 5.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.